Say goodbye to BeiGene as the oncology biopharma becomes BeOne Medicines in rebrand

For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal.

Now, we can count biopharma BeiGene among their ranks as the old iteration of the company is no more: Meet BeOne Medicines Ltd., the new name for the cancer drug maker that launches a new branding journey, shedding the old identity formed back during the company's 2010 inception.